172
Views
0
CrossRef citations to date
0
Altmetric
Research Article

First Example of Hepatocyte Transplantation to Alleviate Ornithine Transcarbamylase Deficiency, Monitored by NMR-Based Metabonomics

, , , , , , , , , , & show all
Pages 1527-1535 | Published online: 07 Dec 2009

Bibliography

  • Puppi J , DhawanA. Human hepatocyte transplantation overview. Methods Mol. Biol. 481, 1–16 (2009).
  • Sze YK , DhawanA, TaylorRMet al. Pediatric liver transplantation for metabolic liver disease: experience at King’s College Hospital. Transplantation87(1), 87–93 (2009).
  • Puppi J , TanN, MitryRRet al. Hepatocyte transplantation followed by auxiliary liver transplantation – a novel treatment for ornithine transcarbamylase deficiency. Am. J. Transplant8(2), 452–457 (2008).
  • Ensenauer R , TuchmanM, El-YoussefMet al. Management and outcome-onset ornithine transcarbamylase deficiency following liver transplantation at 60 days of life. Mol. Genet. Metabol. 84, 363–366 (2005).
  • Horslen SP , McCowanTC, GoertzenTCet al. Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder. Pediatrics111(6), 1262–1267 (2003).
  • Strom SC , FisherMA, ThompsonMTet al. Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. Transplant. Proc. 63, 559–569 (1997).
  • Fox IJ . Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N. Engl. J. Med. 338(20), 1422 (1998).
  • Nicholson JK , WilsonID. High resolution proton magnetic resonance spectroscopy of biological fluids. Prog. Nucl. Magn. Reson. Spectrosc. 21(4–5), 449–501 (1989).
  • Nicholson JK , SpraulM, FarrantRDet al. 750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma. Anal. Chem. 67(5), 793–811 (1995).
  • Waters NJ , GarrodS, FarrantRDet al. High-resolution magic angle spinning 1H NMR spectroscopy of intact liver and kidney: optimization of sample preparation procedures and biochemical stability of tissue during spectral acquisition. Anal. Biochem. 282(1), 16 (2000).
  • Griffin JL , WilliamsHJ, SangEet al. The initial pathogenesis of cadmium-induced renal toxicity. FEBS Lett. 478(1), 147 (2000).
  • Nicholson JK , ConnellyJ, LindonJCet al. Metabonomics: a platform for studying drug toxicity and gene function. Nat. Rev. Drug Discov. 1, 153–161 (2002).
  • Robertson DG , ReilyMD, SiglerREet al. Metabonomics: evaluation of nuclear magnetic resonance (NMR) and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants. Toxicol. Sci. 57(2), 326–337 (2000).
  • Griffin JL , WilliamsHJ, SangEet al. Metabolic profiling of genetic disorders: a multi-tissue 1H nuclear magnetic resonance spectroscopic and pattern recognition study into dystrophic tissue. Anal. Biochem. 293(1), 16 (2001).
  • Nicholson JK , LindonJC, HolmesE. ‘Metabonomics‘: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica29(11), 1181 (1999).
  • Engelke UFH , OostendorpM, WebersRAet al. Handbook of 1H-NMR Spectroscopy in Inborn Errors of Metabolism (2002).
  • Oostendorp M , EngelkeUFH, WillemsenMAet al. Diagnosing inborn errors of lipid metabolism with proton nuclear magnetic resonance spectroscopy. Clin. Chem. 52(7), 1395–1405 (2006).
  • Nicholson JK , WilsonID. Opinion: understanding ‘global’ systems biology: metabonomics and the continuum of metabolism. Nat. Rev. Drug Discov. 2(8), 668–676 (2003).
  • Trygg J . O2-PLS for qualitative and quantitative analysis in multivariate calibration. J. Chemometr. 16(6), 283–293. (2002).
  • Trygg J , WoldS. Orthogonal projections to latent structures (O-PLS). J. Chemometr. 16, 119–128 (2002).
  • Trygg J , WoldS. O2-PLS, a two-block (XY) latent variable regression (LVR) method with an integral OSC filter. J. Chemometr. 17(1), 53–64 (2003).
  • Cloarec O , DumasME, TryggJet al. Evaluation of the orthogonal projection on latent structure model limitations caused by chemical shift variability and improved visualization of biomarker changes in 1H NMR spectroscopic metabonomic studies. Anal. Chem. 77(2), 517–526 (2005).
  • Green AMI , MorganI. Neonatology and Clinical Biochemistry. ACB Venture Publications (1993).
  • Burns SP , WolffDA, LeonardJVet al. Investigation of urea enzyme disorders by 1H-NMR spectroscopy. Clin. Chim. Acta209, 47–60 (1992).
  • Choi C-G , YooHW. Localized proton MR spectroscopy in infants with urea cycle defect. AJNR Am. J. Neuroradiol. 22(5), 834–837 (2001).
  • Kawagishi N , SatohK, EnomotoYet al. Improved quality of life and unchanged magnetic resonance brain imaging after living donor liver transplantation for late-onset ornithine transcarbamylase deficiency: report of a case. Surgery Today35(12), 1087–1091 (2005).
  • Takanashi J-I , BarkovichAJ, ChengSFet al. Brain MR imaging in neonatal hyperammonemic encephalopathy resulting from proximal urea cycle disorders. AJNR Am. J. Neuroradiol. 24(6), 1184–1187 (2003).
  • Dhawan A , MitryRR, HughesRDet al. Hepatocyte transplantation for inherited factor VII deficiency. Transplant. Proc. 78(12), 1812–1814 (2004).
  • Piscitelli S , ThibaultA, FiggWet al. Disposition of phenylbutyrate and its metabolites, phenylacetate and phenylacetylglutamine. J. Clin. Pharmacol. 35(4), 368–373 (1995).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.